No price history available for this symbol yet.
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Sector
Drug Manufacturers - Specialty & Generic
Yuyu Pharma, Inc. specializes in the development and commercialization of pharmaceutical products. Its extensive portfolio encompasses a wide array of prescription drugs designed to address conditions such as osteoporosis, hypocalcemia, various cerebral and peripheral circulatory disorders including tromboembolism, and hypertension. The company also offers therapeutic solutions for respiratory ailments, pulmonary tuberculosis, arthritis, diabetic neuropathy, and eczematous dermatitis, in addition to antibiotics and skeletal muscle relaxants. Furthermore, Yuyu Pharma provides over-the-counter medications and nutritional supplements. Established in 1941, the company was known as YuYu Inc. before officially adopting its current name, Yuyu Pharma, Inc., in May 2008. Its corporate headquarters are located in Seoul, South Korea.
www.yuyu.co.krNo one on the platform currently holds 000227.KS.
No tracked institution reports a position in 000227.KS as of their last filing.
No one on the platform has traded 000227.KS yet.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
Analyst estimates unavailable for this ticker.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Symbol | Price | Today | Mkt cap | P/E |
|---|---|---|---|---|
| 000227.KSYuyu Pharma, Inc. | $7760.00 | -0.39% | $57.7B | — |
| 002630.KSORIENT BIO Inc. | $913.00 | +8.69% | $54.1B | — |
| 002720.KSKUKJE PHARMA Co., Ltd. | $3290.00 | +0.77% | $69.6B | — |
| 004720.KSPharmGen Science, Inc. | $2970.00 | -1.98% | $65.1B | — |
| 017180.KSMYUNGMOON Pharm co.,Ltd | $1308.00 | +5.74% | $43.7B | — |
| 118000.KSMetacare Co., Ltd. | $1284.00 | -0.54% | $22.1B | — |
| 183490.KQEnzychem Lifesciences Corporation | $990.00 | -2.65% | $83.8B | — |
Source: Financial Modeling Prep · peers by sector/industry